Saturday, November 18, 2017 10:39:51 AM
The FDA's move "closes a giant loophole," as the Los Angeles Times' Michael Hiltzik puts it. The law says that if a clinic takes biological material from a person—say by liposuctioning a bit of fat—and then injects that material back into the same person, without changing the material significantly, then the clinic isn't subject to certain rules. The idea is that someone's own tissue is unlikely to pose a danger to herself, so there's less need for strict regulation. In new documents, the FDA specifies which procedures it will continue not to regulate, and which ones it will crack down on.
https://psmag.com/news/food-and-drug-administration-closes-a-loophole-in-stem-cell-clinic-regulations
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM